manilatimes23h
AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.
In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly ...
Hosted on MSN6h
This Penny Stock Just Doubled on Clinical Trial Results. Analysts Think It Can Surge 266% From Here.
Biotechnology is a high-risk, high-reward landscape where innovation determines success. Yet, occasionally, a small player ...